447
Views
29
CrossRef citations to date
0
Altmetric
Reviews

Sclerostin: a possible target for the management of cancer-induced bone disease

, , , , &
Pages 761-769 | Published online: 05 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ayesha Sohail, Lubna Sherin, Saad I Butt, Sana Javed, Zhiwu Li, Sohail Iqbal & O Anwar Be’g. (2018) Role of key players in paradigm shifts of prostate cancer bone metastasis. Cancer Management and Research 10, pages 1619-1626.
Read now
Maria Gavriatopoulou, Meletios A. Dimopoulos, Efstathios Kastritis & Evangelos Terpos. (2017) Emerging treatment approaches for myeloma-related bone disease. Expert Review of Hematology 10:3, pages 217-228.
Read now
Carmel Jacobs, Demetrios Simos, Christina Addison, Mohammed Ibrahim & Mark Clemons. (2014) Pharmacotherapy of bone metastases in breast cancer patients – an update. Expert Opinion on Pharmacotherapy 15:8, pages 1109-1118.
Read now

Articles from other publishers (26)

Kairui Zhang, Courtney Ogando, Alex Filip, Teng Zhang, Jason A Horton & Pranav Soman. (2022) In vitro model to study confined osteocyte networks exposed to flow-induced mechanical stimuli. Biomedical Materials 17:6, pages 065027.
Crossref
Jakub Litak, Wojciech Czyżewski, Michał Szymoniuk, Leon Sakwa, Barbara Pasierb, Joanna Litak, Zofia Hoffman, Piotr Kamieniak & Jacek Roliński. (2022) Biological and Clinical Aspects of Metastatic Spinal Tumors. Cancers 14:19, pages 4599.
Crossref
Edith Bonnelye. 2022. Bone Cancer. Bone Cancer 337 355 .
Yonggang Ma, Di Ran, Xueni Shi, Hongyan Zhao & Zongping Liu. (2021) Cadmium toxicity: A role in bone cell function and teeth development. Science of The Total Environment 769, pages 144646.
Crossref
Alisson Clemenceau, Laetitia Michou, Caroline Diorio & Francine Durocher. (2020) Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?. International Journal of Molecular Sciences 21:22, pages 8613.
Crossref
Paola Maroni & Paola Bendinelli. (2020) Bone, a Secondary Growth Site of Breast and Prostate Carcinomas: Role of Osteocytes. Cancers 12:7, pages 1812.
Crossref
Mengying Zhang, Jinlu Dai & Evan T. Keller. 2020. Encyclopedia of Bone Biology. Encyclopedia of Bone Biology 219 224 .
Adil AkkouchSteven EliasonMason E. SweatMiguel Romero-BustillosMin ZhuFang QianBrad A. AmendtLiu Hong. (2019) Enhancement of MicroRNA-200c on Osteogenic Differentiation and Bone Regeneration by Targeting Sox2-Mediated Wnt Signaling and Klf4. Human Gene Therapy 30:11, pages 1405-1418.
Crossref
Yuan S. Zhang, Hyunju Shim & Eileen M. Crimmins. 2019. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Song Xu, Kim De Veirman, Ann De Becker, Karin Vanderkerken & Ivan Van Riet. (2018) Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?. Leukemia 32:7, pages 1500-1514.
Crossref
Rachelle W. Johnson & Larry J. Suva. (2017) Hallmarks of Bone Metastasis. Calcified Tissue International 102:2, pages 141-151.
Crossref
Else Driehuis & Hans Clevers. (2017) WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer. British Journal of Pharmacology 174:24, pages 4547-4563.
Crossref
Aline G. Costa, Serge Cremers & John P. Bilezikian. (2017) Sclerostin measurement in human disease: Validity and current limitations. Bone 96, pages 24-28.
Crossref
Yusuke Inagaki, Edward S Hookway, Takeshi G Kashima, Mitsuru Munemoto, Yasuhito Tanaka, Andrew Bassim Hassan, Udo Oppermann & Nick A Athanasou. (2016) Sclerostin expression in bone tumours and tumour-like lesions. Histopathology 69:3, pages 470-478.
Crossref
Fei Shen, Yun Zhang, Danielle L. Jernigan, Xin Feng, Jie Yan, Fernando U. Garcia, Olimpia Meucci, Joseph M. Salvino & Alessandro Fatatis. (2016) Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells. Molecular Cancer Research 14:6, pages 518-527.
Crossref
Isabelle Piec, Christopher Washbourne, Jonathan Tang, Emily Fisher, Julie Greeves, Sarah Jackson & William D. Fraser. (2016) How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits. Calcified Tissue International 98:6, pages 546-555.
Crossref
Issam Makhoul, Corey O. Montgomery, Dana Gaddy & Larry J. Suva. (2015) The best of both worlds — managing the cancer, saving the bone. Nature Reviews Endocrinology 12:1, pages 29-42.
Crossref
Julia Dotterweich, Regina Ebert, Sabrina Kraus, Robert J Tower, Franz Jakob & Norbert Schütze. (2014) Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells. Cell Communication and Signaling 12:1.
Crossref
Jocelyn T. Compton & Francis Y. Lee. (2014) A Review of Osteocyte Function and the Emerging Importance of Sclerostin. Journal of Bone and Joint Surgery 96:19, pages 1659-1668.
Crossref
S L Webb & C M Edwards. (2014) Novel therapeutic targets in myeloma bone disease. British Journal of Pharmacology 171:16, pages 3765-3776.
Crossref
Evangelos Terpos, Nikolaos Kanellias & Krzysztof Giannopoulos. (2014) Biology and management of myeloma-related bone disease. Acta Haematologica Polonica 45:2, pages 107-121.
Crossref
Natasa Kovacic, Peter I. Croucher & Michelle M. McDonald. (2013) Signaling Between Tumor Cells and the Host Bone Marrow Microenvironment. Calcified Tissue International 94:1, pages 125-139.
Crossref
Janet E. Brown, Liang Zeng & Caroline Wilson. 2014. Bone Metastases. Bone Metastases 95 124 .
Sandy R. Larson, Xiaotun Zhang, Ruth Dumpit, Ilsa Coleman, Bryce Lakely, Martine Roudier, Celestia S. Higano, Lawrence D. True, Paul H. Lange, Bruce Montgomery, Eva Corey, Peter S. Nelson, Robert L. Vessella & Colm Morrissey. (2013) Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. The Prostate 73:9, pages 932-940.
Crossref
Jesús Delgado-Calle, Jana Arozamena, Javier Pérez-López, Alfonso Bolado-Carrancio, Carolina Sañudo, Gloria Agudo, Rosa de la Vega, María A. Alonso, José Carlos Rodríguez-Rey & José A. Riancho. (2013) Role of BMPs in the regulation of sclerostin as revealed by an epigenetic modifier of human bone cells. Molecular and Cellular Endocrinology 369:1-2, pages 27-34.
Crossref
Evangelos Terpos, Efstathios Kastritis & Meletios A. Dimopoulos. (2012) Prevention and Treatment of Myeloma Bone Disease. Current Hematologic Malignancy Reports 7:4, pages 249-257.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.